Medical Care
Global Biologics Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 564556
- Pages: 139
- Figures: 137
- Views: 5
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biologics Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Sartorius
SGS SA
Charles River
Eurofins Scientific
Lonza
BioReliance
Intertek
PPD
Labcorp
WuXi AppTec
Creative BioMart
Icon
Segment by Type
Biosafety Testing
Stability Testing
Others
Segment by Application
Drug Development
Clinical Trials
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Biologics Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biologics Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Sartorius
SGS SA
Charles River
Eurofins Scientific
Lonza
BioReliance
Intertek
PPD
Labcorp
WuXi AppTec
Creative BioMart
Icon
Segment by Type
Biosafety Testing
Stability Testing
Others
Segment by Application
Drug Development
Clinical Trials
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Biologics Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Biologics Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biologics Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biosafety Testing
1.2.3 Stability Testing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Biologics Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Clinical Trials
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologics Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Biologics Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Biologics Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Biologics Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biosafety Testing Market Size by Players
3.3.2 Stability Testing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Biologics Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biologics Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biologics Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Biologics Testing Service Market Size by Type (2020-2031)
6.4 North America Biologics Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biologics Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Biologics Testing Service Market Size by Type (2020-2031)
7.4 Europe Biologics Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biologics Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Biologics Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Biologics Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Biologics Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Biologics Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Biologics Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biologics Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Biologics Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Biologics Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biologics Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sartorius
11.1.1 Sartorius Corporation Information
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Biologics Testing Service Product Features and Attributes
11.1.4 Sartorius Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Sartorius Biologics Testing Service Revenue by Product in 2024
11.1.6 Sartorius Biologics Testing Service Revenue by Application in 2024
11.1.7 Sartorius Biologics Testing Service Revenue by Geographic Area in 2024
11.1.8 Sartorius Biologics Testing Service SWOT Analysis
11.1.9 Sartorius Recent Developments
11.2 SGS SA
11.2.1 SGS SA Corporation Information
11.2.2 SGS SA Business Overview
11.2.3 SGS SA Biologics Testing Service Product Features and Attributes
11.2.4 SGS SA Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 SGS SA Biologics Testing Service Revenue by Product in 2024
11.2.6 SGS SA Biologics Testing Service Revenue by Application in 2024
11.2.7 SGS SA Biologics Testing Service Revenue by Geographic Area in 2024
11.2.8 SGS SA Biologics Testing Service SWOT Analysis
11.2.9 SGS SA Recent Developments
11.3 Charles River
11.3.1 Charles River Corporation Information
11.3.2 Charles River Business Overview
11.3.3 Charles River Biologics Testing Service Product Features and Attributes
11.3.4 Charles River Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Charles River Biologics Testing Service Revenue by Product in 2024
11.3.6 Charles River Biologics Testing Service Revenue by Application in 2024
11.3.7 Charles River Biologics Testing Service Revenue by Geographic Area in 2024
11.3.8 Charles River Biologics Testing Service SWOT Analysis
11.3.9 Charles River Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Corporation Information
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Biologics Testing Service Product Features and Attributes
11.4.4 Eurofins Scientific Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Eurofins Scientific Biologics Testing Service Revenue by Product in 2024
11.4.6 Eurofins Scientific Biologics Testing Service Revenue by Application in 2024
11.4.7 Eurofins Scientific Biologics Testing Service Revenue by Geographic Area in 2024
11.4.8 Eurofins Scientific Biologics Testing Service SWOT Analysis
11.4.9 Eurofins Scientific Recent Developments
11.5 Lonza
11.5.1 Lonza Corporation Information
11.5.2 Lonza Business Overview
11.5.3 Lonza Biologics Testing Service Product Features and Attributes
11.5.4 Lonza Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Lonza Biologics Testing Service Revenue by Product in 2024
11.5.6 Lonza Biologics Testing Service Revenue by Application in 2024
11.5.7 Lonza Biologics Testing Service Revenue by Geographic Area in 2024
11.5.8 Lonza Biologics Testing Service SWOT Analysis
11.5.9 Lonza Recent Developments
11.6 BioReliance
11.6.1 BioReliance Corporation Information
11.6.2 BioReliance Business Overview
11.6.3 BioReliance Biologics Testing Service Product Features and Attributes
11.6.4 BioReliance Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 BioReliance Recent Developments
11.7 Intertek
11.7.1 Intertek Corporation Information
11.7.2 Intertek Business Overview
11.7.3 Intertek Biologics Testing Service Product Features and Attributes
11.7.4 Intertek Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Intertek Recent Developments
11.8 PPD
11.8.1 PPD Corporation Information
11.8.2 PPD Business Overview
11.8.3 PPD Biologics Testing Service Product Features and Attributes
11.8.4 PPD Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 PPD Recent Developments
11.9 Labcorp
11.9.1 Labcorp Corporation Information
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Biologics Testing Service Product Features and Attributes
11.9.4 Labcorp Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Labcorp Recent Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Corporation Information
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Biologics Testing Service Product Features and Attributes
11.10.4 WuXi AppTec Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative BioMart
11.11.1 Creative BioMart Corporation Information
11.11.2 Creative BioMart Business Overview
11.11.3 Creative BioMart Biologics Testing Service Product Features and Attributes
11.11.4 Creative BioMart Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Creative BioMart Recent Developments
11.12 Icon
11.12.1 Icon Corporation Information
11.12.2 Icon Business Overview
11.12.3 Icon Biologics Testing Service Product Features and Attributes
11.12.4 Icon Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Icon Recent Developments
12 Biologics Testing ServiceIndustry Chain Analysis
12.1 Biologics Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biologics Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biologics Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Biologics Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biologics Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biosafety Testing
1.2.3 Stability Testing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Biologics Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Clinical Trials
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologics Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Biologics Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Biologics Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Biologics Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biosafety Testing Market Size by Players
3.3.2 Stability Testing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Biologics Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biologics Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biologics Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Biologics Testing Service Market Size by Type (2020-2031)
6.4 North America Biologics Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biologics Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Biologics Testing Service Market Size by Type (2020-2031)
7.4 Europe Biologics Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biologics Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Biologics Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Biologics Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Biologics Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Biologics Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Biologics Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biologics Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Biologics Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Biologics Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biologics Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sartorius
11.1.1 Sartorius Corporation Information
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Biologics Testing Service Product Features and Attributes
11.1.4 Sartorius Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Sartorius Biologics Testing Service Revenue by Product in 2024
11.1.6 Sartorius Biologics Testing Service Revenue by Application in 2024
11.1.7 Sartorius Biologics Testing Service Revenue by Geographic Area in 2024
11.1.8 Sartorius Biologics Testing Service SWOT Analysis
11.1.9 Sartorius Recent Developments
11.2 SGS SA
11.2.1 SGS SA Corporation Information
11.2.2 SGS SA Business Overview
11.2.3 SGS SA Biologics Testing Service Product Features and Attributes
11.2.4 SGS SA Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 SGS SA Biologics Testing Service Revenue by Product in 2024
11.2.6 SGS SA Biologics Testing Service Revenue by Application in 2024
11.2.7 SGS SA Biologics Testing Service Revenue by Geographic Area in 2024
11.2.8 SGS SA Biologics Testing Service SWOT Analysis
11.2.9 SGS SA Recent Developments
11.3 Charles River
11.3.1 Charles River Corporation Information
11.3.2 Charles River Business Overview
11.3.3 Charles River Biologics Testing Service Product Features and Attributes
11.3.4 Charles River Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Charles River Biologics Testing Service Revenue by Product in 2024
11.3.6 Charles River Biologics Testing Service Revenue by Application in 2024
11.3.7 Charles River Biologics Testing Service Revenue by Geographic Area in 2024
11.3.8 Charles River Biologics Testing Service SWOT Analysis
11.3.9 Charles River Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Corporation Information
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Biologics Testing Service Product Features and Attributes
11.4.4 Eurofins Scientific Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Eurofins Scientific Biologics Testing Service Revenue by Product in 2024
11.4.6 Eurofins Scientific Biologics Testing Service Revenue by Application in 2024
11.4.7 Eurofins Scientific Biologics Testing Service Revenue by Geographic Area in 2024
11.4.8 Eurofins Scientific Biologics Testing Service SWOT Analysis
11.4.9 Eurofins Scientific Recent Developments
11.5 Lonza
11.5.1 Lonza Corporation Information
11.5.2 Lonza Business Overview
11.5.3 Lonza Biologics Testing Service Product Features and Attributes
11.5.4 Lonza Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Lonza Biologics Testing Service Revenue by Product in 2024
11.5.6 Lonza Biologics Testing Service Revenue by Application in 2024
11.5.7 Lonza Biologics Testing Service Revenue by Geographic Area in 2024
11.5.8 Lonza Biologics Testing Service SWOT Analysis
11.5.9 Lonza Recent Developments
11.6 BioReliance
11.6.1 BioReliance Corporation Information
11.6.2 BioReliance Business Overview
11.6.3 BioReliance Biologics Testing Service Product Features and Attributes
11.6.4 BioReliance Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 BioReliance Recent Developments
11.7 Intertek
11.7.1 Intertek Corporation Information
11.7.2 Intertek Business Overview
11.7.3 Intertek Biologics Testing Service Product Features and Attributes
11.7.4 Intertek Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Intertek Recent Developments
11.8 PPD
11.8.1 PPD Corporation Information
11.8.2 PPD Business Overview
11.8.3 PPD Biologics Testing Service Product Features and Attributes
11.8.4 PPD Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 PPD Recent Developments
11.9 Labcorp
11.9.1 Labcorp Corporation Information
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Biologics Testing Service Product Features and Attributes
11.9.4 Labcorp Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Labcorp Recent Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Corporation Information
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Biologics Testing Service Product Features and Attributes
11.10.4 WuXi AppTec Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative BioMart
11.11.1 Creative BioMart Corporation Information
11.11.2 Creative BioMart Business Overview
11.11.3 Creative BioMart Biologics Testing Service Product Features and Attributes
11.11.4 Creative BioMart Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Creative BioMart Recent Developments
11.12 Icon
11.12.1 Icon Corporation Information
11.12.2 Icon Business Overview
11.12.3 Icon Biologics Testing Service Product Features and Attributes
11.12.4 Icon Biologics Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Icon Recent Developments
12 Biologics Testing ServiceIndustry Chain Analysis
12.1 Biologics Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biologics Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biologics Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Biologics Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biologics Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biologics Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biologics Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologics Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Biologics Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Biologics Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Biologics Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Testing Service as of 2024)
Table 11. Global Biologics Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Biologics Testing Service Companies Headquarters
Table 13. Global Biologics Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Biologics Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Biologics Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Biologics Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Biologics Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Biologics Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Biologics Testing Service Growth Accelerators and Market Barriers
Table 25. North America Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Biologics Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Biologics Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Biologics Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Biologics Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Biologics Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Biologics Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Sartorius Corporation Information
Table 35. Sartorius Description and Major Businesses
Table 36. Sartorius Product Features and Attributes
Table 37. Sartorius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Sartorius Revenue Proportion by Product in 2024
Table 39. Sartorius Revenue Proportion by Application in 2024
Table 40. Sartorius Revenue Proportion by Geographic Area in 2024
Table 41. Sartorius Biologics Testing Service SWOT Analysis
Table 42. Sartorius Recent Developments
Table 43. SGS SA Corporation Information
Table 44. SGS SA Description and Major Businesses
Table 45. SGS SA Product Features and Attributes
Table 46. SGS SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SGS SA Revenue Proportion by Product in 2024
Table 48. SGS SA Revenue Proportion by Application in 2024
Table 49. SGS SA Revenue Proportion by Geographic Area in 2024
Table 50. SGS SA Biologics Testing Service SWOT Analysis
Table 51. SGS SA Recent Developments
Table 52. Charles River Corporation Information
Table 53. Charles River Description and Major Businesses
Table 54. Charles River Product Features and Attributes
Table 55. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Charles River Revenue Proportion by Product in 2024
Table 57. Charles River Revenue Proportion by Application in 2024
Table 58. Charles River Revenue Proportion by Geographic Area in 2024
Table 59. Charles River Biologics Testing Service SWOT Analysis
Table 60. Charles River Recent Developments
Table 61. Eurofins Scientific Corporation Information
Table 62. Eurofins Scientific Description and Major Businesses
Table 63. Eurofins Scientific Product Features and Attributes
Table 64. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Eurofins Scientific Revenue Proportion by Product in 2024
Table 66. Eurofins Scientific Revenue Proportion by Application in 2024
Table 67. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 68. Eurofins Scientific Biologics Testing Service SWOT Analysis
Table 69. Eurofins Scientific Recent Developments
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Major Businesses
Table 72. Lonza Product Features and Attributes
Table 73. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Lonza Revenue Proportion by Product in 2024
Table 75. Lonza Revenue Proportion by Application in 2024
Table 76. Lonza Revenue Proportion by Geographic Area in 2024
Table 77. Lonza Biologics Testing Service SWOT Analysis
Table 78. Lonza Recent Developments
Table 79. BioReliance Corporation Information
Table 80. BioReliance Description and Major Businesses
Table 81. BioReliance Product Features and Attributes
Table 82. BioReliance Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BioReliance Recent Developments
Table 84. Intertek Corporation Information
Table 85. Intertek Description and Major Businesses
Table 86. Intertek Product Features and Attributes
Table 87. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Intertek Recent Developments
Table 89. PPD Corporation Information
Table 90. PPD Description and Major Businesses
Table 91. PPD Product Features and Attributes
Table 92. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. PPD Recent Developments
Table 94. Labcorp Corporation Information
Table 95. Labcorp Description and Major Businesses
Table 96. Labcorp Product Features and Attributes
Table 97. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Labcorp Recent Developments
Table 99. WuXi AppTec Corporation Information
Table 100. WuXi AppTec Description and Major Businesses
Table 101. WuXi AppTec Product Features and Attributes
Table 102. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. WuXi AppTec Recent Developments
Table 104. Creative BioMart Corporation Information
Table 105. Creative BioMart Description and Major Businesses
Table 106. Creative BioMart Product Features and Attributes
Table 107. Creative BioMart Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Creative BioMart Recent Developments
Table 109. Icon Corporation Information
Table 110. Icon Description and Major Businesses
Table 111. Icon Product Features and Attributes
Table 112. Icon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Icon Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Testing Service Product Picture
Figure 2. Global Biologics Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biosafety Testing Product Picture
Figure 4. Stability Testing Product Picture
Figure 5. Others Product Picture
Figure 6. Global Biologics Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Drug Development
Figure 8. Clinical Trials
Figure 9. Others
Figure 10. Biologics Testing Service Report Years Considered
Figure 11. Global Biologics Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 13. Global Biologics Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Biologics Testing Service Revenue Market Share by Region (2020-2031)
Figure 15. Global Biologics Testing Service Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Biosafety Testing Revenue Market Share by Player in 2024
Figure 18. Stability Testing Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Biologics Testing Service Revenue Market Share by Type (2020-2031)
Figure 21. Global Biologics Testing Service Revenue Market Share by Application (2020-2031)
Figure 22. North America Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 24. North America Biologics Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 31. Europe Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. France Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. India Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 54. Central and South America Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 60. South America Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 66. Biologics Testing Service Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Biologics Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biologics Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biologics Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biologics Testing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologics Testing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Biologics Testing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Biologics Testing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Biologics Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Testing Service as of 2024)
Table 11. Global Biologics Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Biologics Testing Service Companies Headquarters
Table 13. Global Biologics Testing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Biologics Testing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Biologics Testing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Biologics Testing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Biologics Testing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Biologics Testing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Biologics Testing Service Growth Accelerators and Market Barriers
Table 25. North America Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Biologics Testing Service Growth Accelerators and Market Barriers
Table 27. Europe Biologics Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Biologics Testing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Biologics Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Biologics Testing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Biologics Testing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Biologics Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Sartorius Corporation Information
Table 35. Sartorius Description and Major Businesses
Table 36. Sartorius Product Features and Attributes
Table 37. Sartorius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Sartorius Revenue Proportion by Product in 2024
Table 39. Sartorius Revenue Proportion by Application in 2024
Table 40. Sartorius Revenue Proportion by Geographic Area in 2024
Table 41. Sartorius Biologics Testing Service SWOT Analysis
Table 42. Sartorius Recent Developments
Table 43. SGS SA Corporation Information
Table 44. SGS SA Description and Major Businesses
Table 45. SGS SA Product Features and Attributes
Table 46. SGS SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SGS SA Revenue Proportion by Product in 2024
Table 48. SGS SA Revenue Proportion by Application in 2024
Table 49. SGS SA Revenue Proportion by Geographic Area in 2024
Table 50. SGS SA Biologics Testing Service SWOT Analysis
Table 51. SGS SA Recent Developments
Table 52. Charles River Corporation Information
Table 53. Charles River Description and Major Businesses
Table 54. Charles River Product Features and Attributes
Table 55. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Charles River Revenue Proportion by Product in 2024
Table 57. Charles River Revenue Proportion by Application in 2024
Table 58. Charles River Revenue Proportion by Geographic Area in 2024
Table 59. Charles River Biologics Testing Service SWOT Analysis
Table 60. Charles River Recent Developments
Table 61. Eurofins Scientific Corporation Information
Table 62. Eurofins Scientific Description and Major Businesses
Table 63. Eurofins Scientific Product Features and Attributes
Table 64. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Eurofins Scientific Revenue Proportion by Product in 2024
Table 66. Eurofins Scientific Revenue Proportion by Application in 2024
Table 67. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 68. Eurofins Scientific Biologics Testing Service SWOT Analysis
Table 69. Eurofins Scientific Recent Developments
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Major Businesses
Table 72. Lonza Product Features and Attributes
Table 73. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Lonza Revenue Proportion by Product in 2024
Table 75. Lonza Revenue Proportion by Application in 2024
Table 76. Lonza Revenue Proportion by Geographic Area in 2024
Table 77. Lonza Biologics Testing Service SWOT Analysis
Table 78. Lonza Recent Developments
Table 79. BioReliance Corporation Information
Table 80. BioReliance Description and Major Businesses
Table 81. BioReliance Product Features and Attributes
Table 82. BioReliance Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BioReliance Recent Developments
Table 84. Intertek Corporation Information
Table 85. Intertek Description and Major Businesses
Table 86. Intertek Product Features and Attributes
Table 87. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Intertek Recent Developments
Table 89. PPD Corporation Information
Table 90. PPD Description and Major Businesses
Table 91. PPD Product Features and Attributes
Table 92. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. PPD Recent Developments
Table 94. Labcorp Corporation Information
Table 95. Labcorp Description and Major Businesses
Table 96. Labcorp Product Features and Attributes
Table 97. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Labcorp Recent Developments
Table 99. WuXi AppTec Corporation Information
Table 100. WuXi AppTec Description and Major Businesses
Table 101. WuXi AppTec Product Features and Attributes
Table 102. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. WuXi AppTec Recent Developments
Table 104. Creative BioMart Corporation Information
Table 105. Creative BioMart Description and Major Businesses
Table 106. Creative BioMart Product Features and Attributes
Table 107. Creative BioMart Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Creative BioMart Recent Developments
Table 109. Icon Corporation Information
Table 110. Icon Description and Major Businesses
Table 111. Icon Product Features and Attributes
Table 112. Icon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Icon Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Testing Service Product Picture
Figure 2. Global Biologics Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biosafety Testing Product Picture
Figure 4. Stability Testing Product Picture
Figure 5. Others Product Picture
Figure 6. Global Biologics Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Drug Development
Figure 8. Clinical Trials
Figure 9. Others
Figure 10. Biologics Testing Service Report Years Considered
Figure 11. Global Biologics Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 13. Global Biologics Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Biologics Testing Service Revenue Market Share by Region (2020-2031)
Figure 15. Global Biologics Testing Service Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Biosafety Testing Revenue Market Share by Player in 2024
Figure 18. Stability Testing Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Biologics Testing Service Revenue Market Share by Type (2020-2031)
Figure 21. Global Biologics Testing Service Revenue Market Share by Application (2020-2031)
Figure 22. North America Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 24. North America Biologics Testing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 31. Europe Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 34. France Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 46. India Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Biologics Testing Service Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 54. Central and South America Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Biologics Testing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Biologics Testing Service Revenue (US$ Million) in 2024
Figure 60. South America Biologics Testing Service Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Biologics Testing Service Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Biologics Testing Service Revenue (2020-2025) & (US$ Million)
Figure 66. Biologics Testing Service Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232